The Asia Pacific diagnostic imaging equipment market size is projected to expand at a significant CAGR during the forecast period, 2021-2028. The growth of the market is attributed to growing geriatric population.
Diagnostic imaging is also known as medical imaging. The use of diagnostic imaging equipment is to produce images of interior body for diagnostic and therapeutic purposes. Radiology is the branch of medicine that uses radiation to diagnose and treat diseases. Various technologies such as ultrasound and endoscopy are widely used for capturing images and diagnosis diseases properly.
The diagnostics imaging equipment market was positively impacted due to rising health consciousness during amidst COVID-19 pandemic.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing technological advancements in diagnostic imaging devices is anticipated to drive the market growth during the forecast period.
- Rising incidence of chronic diseases is projected to boost the market growth in the coming years.
- Growing number of medical imaging procedures and rising awareness for early diagnosis of clinical disorders planning is expected to spur the market growth during the forecast period.
- Increasing large undiagnosed patient population is anticipated to drive the market growth during the forecast period.
- Rising urbanization is projected to boost the market growth in the coming years.
- Growing disposable income is expected to spur the market growth during the forecast period.
- Increasing government funding toward chronic disorders is anticipated to drive the market growth during the forecast period.
- Growing awareness about early diagnosis of diseases is projected to boost the market growth in the coming years.
- High cost of imaging modalities and unfavorable reimbursement scenario in emerging countries can restrict the market growth.
- Increasing healthcare spending in emerging markets can create lucrative opportunities in the market growth.
Scope of the Report
The report on the Asia Pacific diagnostics imaging equipment market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Diagnostic Imaging Equipment Market - Asia Pacific Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2020
|
Historic Data
|
2018–2019
|
Forecast Period
|
2021–2028
|
Segmentation
|
Modalities (MRI [Low and Mid field MRI systems (< 1.5 T), High Field MRI systems (1.5-3 T), Very High, and Ultra High Field MRI Systems (3T and more)], Computed Tomography [Low End Scanners (~16-Slice), Mid-range Scanners (~64-Slice), and High End Scanners (128-Slice and More)], Ultrasound [2D Ultrasound, 3D Ultrasound, and Others], X-Ray [Analog Systems and Digital Systems], Nuclear Imaging [Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT)], Fluoroscopy, and Mammography), Applications (Cardiology, Oncology, Neurology, Orthopaedics, Gastroenterology, Gynaecology, and Others), and End-users (Hospitals, Diagnostic Centres, and Others)
|
Geographical Scope
|
China, India, Japan, Australia and Rest of Asia Pacific
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Care stream Health; Fujifilm Holdings Corporation; GE Healthcare; Hitachi Medical Corporation; Hologic, Inc.; Koninklijke Philips N.V.; Shimadzu Corporation; Siemens AG; Canon Medical Systems Corporation; and Shanghai United Imaging Healthcare Co., Ltd.
|
Asia Pacific Diagnostic Imaging Equipment Market Segment Insights
Fluoroscopy segment to hold a significant market share
Based on modalities, the market is divided into MRI, computed tomography, ultrasound, X-Ray, nuclear imaging, fluoroscopy, and mammography. The MRI is segmented into low and mid field MRI systems (< 1.5 T), high field MRI systems (1.5-3 T), very high, and ultra-high field MRI Systems (3T and more). The computed tomography segment is segregated into low end scanners (~16-Slice), mid-range scanners (~64-Slice), and high end scanners (128-Slice and More). The ultrasound segment is divided into 2D ultrasound, 3D ultrasound, and others. The X-Ray segment is bifurcated into analog systems and digital systems. The nuclear imaging is segmented into positron emission tomography (PET) and single photon emission computed tomography (SPECT).
The computed tomography segment is anticipated to hold a key share of the market in the coming years, as it enables the doctors to watch vital organs, identify blockages and growth, and diagnose signs of diseases without doing surgery. However, the fluoroscopy segment is anticipated to expand at a rapid pace during the forecast period, as it allows doctors to diagnose in a bright environment and its dosage is low.
Orthopaedics segment is anticipated to hold a large market share
On the basis of applications, the market is segmented into cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, and others. The oncology segment is projected to constitute a major market share during the forecast period due to enhanced cancer detection facilities and presence of high speed noninvasive diagnosis using genomics and proteomics. On the other hand, the orthopedics segment is anticipated to expand at a rapid pace during the forecast period owing to reduced pain and improved range of motion in the affected joints.
Hospitals segment to hold a significant market share
Based on end users, the market is divided into hospitals, diagnostics centres, and others. The diagnostics centres segment is anticipated to hold a key share of the market in the coming years due to improvement in patient care and reduced healthcare spending. However, the hospitals segment is anticipated to expand at a rapid pace during the forecast period.
India is estimated to account a major market share
On the basis of geography, the Asia Pacific market is classified as India, China, Japan, Australia, and Rest of Asia Pacific. China is expected to constitute a significant share of the market during the projected period due to the improvement healthcare infrastructure and reimbursement scenario and growing insurance coverage in China. However, the market in India is anticipated to expand at a rapid pace during the forecast period owing to rising investments in diagnostic imaging.
Segments
Segments Covered in the Report
The Asia Pacific diagnostics imaging equipment market has been segmented on the basis
Modalities
- MRI
- Low and Mid Field MRI systems (<1.5 T)
- High Field MRI systems (1.5-3 T)
- Very High
- Ultra High Field MRI Systems (3T and more)
- Computed Tomography
- Low End Scanners (~16-Slice)
- Mid-Range Scanners (~64-Slice)
- High End Scanners (128-Slice and More)
- Ultrasound
- 2D Ultrasound
- 3D Ultrasound
- Others
- X-ray
- Analog Systems
- Digital Systems
- Nuclear Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Fluoroscopy
- Mammography
Applications
- Cardiology
- Oncology
- Neurology
- Orthopedics
- Gastroenterology
- Gynecology
- Others
End-users
- Hospitals
- Diagnostic Centers
- Others
Geography
- China
- India
- Japan
- Australia
- Rest of Asia-pacific
Key Players
- Care stream Health
- Fujifilm Holdings Corporation
- GE Healthcare
- Hitachi Medical Corporation
- Hologic, Inc.
- Koninklijke Philips N.V.
- Shimadzu Corporation
- Siemens AG
- Canon Medical Systems Corporation
- Shanghai United Imaging Healthcare Co., Ltd.
Competitive Landscape
Key players competing in the Asia Pacific diagnostics imaging equipment market includes Care Stream Health; Fujifilm Holdings Corporation; GE Healthcare; Hitachi Medical Corporation; Hologic, Inc.; Koninklijke Philips N.V.; Shimadzu Corporation; Siemens AG; Canon Medical Systems Corporation; and Shanghai United Imaging Healthcare Co., Ltd.
Some of these players are engaging in business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market share.
